Johannes Weller

Lomustine-temozolomide combination therapy versus standard temozolomide therapy in patients with newly diagnosed glioblastoma with methylated MGMT promoter (CeTeG/NOA–09): a randomised, open-label, phase 3 trial

Ulrich Herrlinger, Theophilos Tzaridis, Frederic Mack et al. · The Lancet · 2019 · 556 citations · Full text

Hematological Malignancy, Neuro-oncology, Treatment Strategies +13

Endovascular thrombectomy for acute ischaemic stroke with established large infarct: multicentre, open-label, randomised trial

Martin Bendszus, Jens Fiehler, Fabien Subtil et al. · The Lancet · 2023 · 394 citations

Thrombosis, Endovascular Thrombectomy, Endovascular Technique +13

Prognostic validation and clinical implications of the EANO ESMO classification of leptomeningeal metastasis from solid tumors

Émilie Le Rhun, Patrick Devos, Johannes Weller et al. · Neuro-Oncology · 2020 · 112 citations · Full text

Newly diagnosed glioblastoma in geriatric (65 +) patients: impact of patients frailty, comorbidity burden and obesity on overall survival

Matthias Schneider, Anna‐Laura Potthoff, Elisa Scharnböck et al. · Journal of Neuro-Oncology · 2020 · 53 citations · Full text

Endovascular thrombectomy for acute ischaemic stroke with established large infarct (TENSION): 12-month outcomes of a multicentre, open-label, randomised trial

Götz Thomalla, Jens Fiehler, Fabien Subtil et al. · The Lancet Neurology · 2024 · 52 citations · Full text